Related Experiment Video
Updated: May 13, 2026

09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets
Yumiko Matsubara1, Yukako Ono, Hidenori Suzuki
1Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan. yumikoma@a7.keio.jp
Plos One
|March 8, 2013
Summary
OP9 cells, a pre-adipocyte cell line, can differentiate into megakaryocytes (MKs) and functional platelets. Overexpressing the transcription factor p45NF-E2 enhances this platelet production process.
Area of Science:
- Hematology
- Cell Biology
- Developmental Biology
Background:
- Megakaryocyte (MK) differentiation and platelet production are crucial for hemostasis but remain incompletely understood.
- The OP9 mouse bone marrow stroma cell line is commonly used as feeder cells for stem cell differentiation.
- Previous studies showed 3T3-L1 pre-adipocytes can differentiate into MKs and platelets.
Purpose of the Study:
- To investigate whether OP9 cells can differentiate into MKs and functional platelets.
- To analyze the gene expression of key factors regulating megakaryopoiesis and thrombopoiesis during OP9 cell differentiation.
- To determine the role of p45NF-E2 in OP9 cell differentiation into MK lineages.
Main Methods:
- OP9 cells were cultured in MK lineage induction (MKLI) medium.
- Megakaryocytic features were assessed by surface marker expression (CD41, CD42b), polyploidy, and morphology.
- Functional assays were performed on OP9-derived platelets.
- Gene expression of transcription factors (p45NF-E2, FOG, Fli1, GATA2, RUNX1) and signaling molecules (thrombopoietin, c-mpl) was analyzed.
- p45NF-E2 was overexpressed in OP9 cells to study its effect on MK and platelet generation.
Main Results:
- OP9 cells cultured in MKLI medium exhibited megakaryocytic characteristics, including CD41/CD42b expression, polyploidy, and characteristic morphology.
- OP9-derived platelets demonstrated functional capabilities, confirming differentiation into MKs and platelets.
- Gene expression analysis revealed the presence and dynamic changes of critical megakaryopoiesis and thrombopoiesis factors, with increased p45NF-E2 expression during differentiation.
- Overexpression of p45NF-E2 in OP9 cells led to enhanced production of MKs and platelets.
Conclusions:
- OP9 cells are capable of differentiating into MKs and producing functional platelets in vitro.
- OP9 cells possess critical factors involved in megakaryopoiesis and thrombopoiesis, contributing to their differentiation potential.
- The transcription factor p45NF-E2 plays a significant role in promoting the differentiation of OP9 cells into the MK lineage.
Related Concept Videos
Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Lineage Commitment
Commitment is the process whereby stem cells:
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

